EPYC Human

Epiphycan Human Recombinant
Cat. No.
BT6990
Source

HEK293 Cells.

Synonyms

Epiphycan, SLRR3B, DSPG3, EPYC Dermatan sulfate proteoglycan 3, Proteoglycan-Lb, PG-Lb, Small chondroitin/dermatan sulfate proteoglycan, PGLB, epiphycan proteoglycan.

Appearance
Sterile Filtered colorless solution.
Purity

Greater than 95.0% as determined by SDS-PAGE.

Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

EPYC Human Recombinant produced in HEK293 Cells.is a single, glycosylated polypeptide chain containing 309 amino acids (20-322 a.a.) and having a molecular mass of 35.5kDa. EPYC is fused to a 6 amino acid His-tag at C-terminus and is purified by proprietary chromatographic techniques.

Product Specs

Description
Recombinant human EPYC protein, expressed in HEK293 cells, comprises a single glycosylated polypeptide chain of 309 amino acids (residues 20-322) with a molecular weight of 35.5 kDa. The protein includes a C-terminal 6-amino acid His-tag and is purified using proprietary chromatographic methods.
Physical Appearance
Clear, colorless, and sterile-filtered solution.
Formulation
The EPYC protein is provided at a concentration of 0.5 mg/ml in a solution containing 10% glycerol and Phosphate-Buffered Saline (pH 7.4).
Stability
For short-term storage (up to 4 weeks), the protein can be stored at 4°C. For extended storage, it is recommended to freeze the protein at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Repeated freezing and thawing cycles should be avoided.
Purity
The purity is determined to be greater than 95.0% by SDS-PAGE analysis.
Biological Activity
The biological activity is assessed to be greater than 60%. This determination is based on the protein's ability, when immobilized, to promote the adhesion of Saos-2 human osteosarcoma cells to plates coated with 1.25 µg/ml of human DSPG3 and 0.5 µg/ml of human fibronectin.
Synonyms

Epiphycan, SLRR3B, DSPG3, EPYC Dermatan sulfate proteoglycan 3, Proteoglycan-Lb, PG-Lb, Small chondroitin/dermatan sulfate proteoglycan, PGLB, epiphycan proteoglycan.

Source

HEK293 Cells.

Amino Acid Sequence

APTLESINYD SETYDATLED LDNLYNYENI PVDKVEIEIA TVMPSGNREL LTPPPQPEKA QEEEEEEEST PRLIDGSSPQ EPEFTGVLGP HTNEDFPTCL LCTCISTTVY CDDHELDAIP PLPKNTAYFY SRFNRIKKIN KNDFASLSDL KRIDLTSNLI SEIDEDAFRK LPQLRELVLR DNKIRQLPEL PTTLTFIDIS NNRLGRKGIK QEAFKDMYDL HHLYLTDNNL DHIPLPLPEN LRALHLQNNN ILEMHEDTFC NVKNLTYIRK ALEDIRLDGN PINLSKTPQA YMCLPRLPVG SLVHHHHHH.

Product Science Overview

Introduction

Epiphycan, also known as dermatan sulfate proteoglycan 3 (DSPG3), is a member of the small leucine-rich proteoglycan (SLRP) family. This protein plays a significant role in the extracellular matrix, particularly in skeletal tissues such as the growth plate of long bones, articular cartilage, and intervertebral discs . The recombinant form of human epiphycan is produced using advanced biotechnological methods, often involving expression in HEK293 cells .

Structure and Composition

Epiphycan is composed of a core protein with attached glycosaminoglycan (GAG) chains. The human recombinant form of epiphycan typically consists of a single, glycosylated polypeptide chain containing 309 amino acids, with a molecular mass of approximately 35.5 kDa . The protein is often fused to a His-tag at the C-terminus to facilitate purification .

Biological Functions

Epiphycan is involved in various biological processes, primarily related to tissue development, repair, and homeostasis. It interacts with collagen fibrils and other extracellular matrix proteins, regulating fibrillogenesis and influencing cell behavior and tissue organization . The unique structure of epiphycan allows it to bind to growth factors, cytokines, and other matrix proteins, thereby modulating their activity and availability .

Therapeutic Potential

The involvement of epiphycan in tissue development and repair has highlighted its potential as a therapeutic target. Research suggests that epiphycan may play a role in bone formation and the establishment of the ordered structure of cartilage through matrix organization . Its ability to interact with various growth factors and cytokines makes it a promising candidate for therapeutic interventions in conditions related to tissue damage and repair .

Production and Purification

Human recombinant epiphycan is produced using HEK293 cells, a widely used cell line for recombinant protein expression. The protein is purified using proprietary chromatographic techniques to achieve a purity greater than 95%, as determined by SDS-PAGE . The recombinant protein is typically formulated in a sterile, colorless solution containing glycerol and phosphate-buffered saline (PBS) at pH 7.4 .

Storage and Stability

For optimal stability, human recombinant epiphycan should be stored at 4°C if used within 2-4 weeks. For longer storage periods, it is recommended to freeze the protein at -20°C, with the addition of a carrier protein such as human serum albumin (HSA) or bovine serum albumin (BSA) to prevent degradation . It is important to avoid multiple freeze-thaw cycles to maintain the protein’s integrity and biological activity .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.